Form 4: Stryker Corp CEO Kevin Lobo Executes Stock Option and Sells Shares

Kevin Lobo, Chair and CEO of Stryker Corp, exercised stock options and sold shares of common stock on November 7, 2024, according to a Form 4 filing with the SEC.

Summary

• On November 7, 2024, Kevin Lobo, the Chair and CEO of Stryker Corp, exercised employee stock options granted on February 11, 2015, to acquire 156,890 shares of Stryker common stock at a price of $93.06 per share.
• Following the exercise of the options, Lobo sold a total of 57,313 shares of Stryker common stock in multiple transactions at weighted average prices ranging from $367.95 to $369.75.
• The sales were executed in three separate transactions with 18,269 shares sold at an average price of $367.95, 23,178 shares sold at an average price of $368.58, and 15,866 shares sold at an average price of $369.75.
• After these transactions, Lobo directly owns 100,027 shares of Stryker common stock and indirectly owns 695 shares through a 401K.
• Additionally, 99,577 shares were disposed of for $369.02.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions. Monitoring such filings provides insights into management's perspective on the company's valuation and future prospects. It is common for executives to exercise stock options and sell shares for personal financial management.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The exercise and sale of shares by Stryker's CEO is a common practice among executives in publicly traded companies, including competitors like Medtronic and Johnson & Johnson.
• The timing and volume of these transactions are closely watched by investors for signals about the executive's confidence in the company's future performance.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the routine nature of such transactions.
• Employees holding Stryker stock or options may be interested in the CEO's transactions as a signal of management's view on the company's value.

Key Dates